ARTICLE | Company News
Curtana Pharmaceuticals, University of California deal
December 9, 2013 8:00 AM UTC
In September, newco Curtana received exclusive, worldwide rights to preclinical small molecule inhibitors against oligodendrocyte transcription factor 2 (OLIG2) from the university to treat glioblast...